Literature DB >> 20739354

In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.

Sangwon Cha1, Marcin B Imielinski, Tomas Rejtar, Elizabeth A Richardson, Dipak Thakur, Dennis C Sgroi, Barry L Karger.   

Abstract

Identification of molecular signatures that allow detection of the transition from normal breast epithelial cells to malignant invasive cells is a critical component in the development of diagnostic, therapeutic, and preventative strategies for human breast cancer. Substantial efforts have been devoted to deciphering breast cancer etiology at the genome level, but only a limited number of studies have appeared at the proteome level. In this work, we compared individual in situ proteome profiles of nonpatient matched nine noncancerous, normal breast epithelial (NBE) samples with nine estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples by combining laser capture microdissection (LCM) and quantitative shotgun proteomics. A total of 12,970 unique peptides were identified from the 18 samples, and 1623 proteins were selected for quantitative analysis using spectral index (SpI) as a measure of protein abundance. A total of 298 proteins were differentially expressed between NBE and MBE at 95% confidence level, and this differential expression correlated well with immunohistochemistry (IHC) results reported in the Human Protein Atlas (HPA) database. To assess pathway level patterns in the observed expression changes, we developed protein set enrichment analysis (PSEA), a modification of a well-known approach in gene expression analysis, Gene Set Enrichment Analysis (GSEA). Unlike single gene-based functional term enrichment analyses that only examines pathway overrepresentation of proteins above a given significance threshold, PSEA applies a weighted running sum statistic to the entire expression data to discover significantly enriched protein groups. Application of PSEA to the expression data in this study revealed not only well-known ER-dependent and cellular morphology-dependent protein abundance changes, but also significant alterations of downstream targets for multiple transcription factors (TFs), suggesting a role for specific gene regulatory pathways in breast tumorigenesis. A parallel GOMiner analysis revealed both confirmatory and complementary data to PSEA. The combination of the two annotation approaches yielded extensive biological feature mapping for in depth analysis of the quantitative proteomic data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739354      PMCID: PMC2984225          DOI: 10.1074/mcp.M110.000398

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  79 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  Aminoacyl-tRNA synthetases: potential markers of genetic code development.

Authors:  L Ribas de Pouplana; P Schimmel
Journal:  Trends Biochem Sci       Date:  2001-10       Impact factor: 13.807

3.  Laser-capture microdissection.

Authors:  Virginia Espina; Julia D Wulfkuhle; Valerie S Calvert; Amy VanMeter; Weidong Zhou; George Coukos; David H Geho; Emanuel F Petricoin; Lance A Liotta
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  ERE-independent ERalpha target genes differentially expressed in human breast tumors.

Authors:  Christine Glidewell-Kenney; Jeffrey Weiss; Eun-Jig Lee; Suresh Pillai; Toshio Ishikawa; Eric A Ariazi; J Larry Jameson
Journal:  Mol Cell Endocrinol       Date:  2005-11-17       Impact factor: 4.102

5.  Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.

Authors:  Stacey R Oppenheimer; Deming Mi; Melinda E Sanders; Richard M Caprioli
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Inhibition of transforming growth factor beta-enhanced serum response factor-dependent transcription by SMAD7.

Authors:  Blanca Camoretti-Mercado; Darren J Fernandes; Samantha Dewundara; Jason Churchill; Lan Ma; Paul C Kogut; John F McConville; Michael S Parmacek; Julian Solway
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

8.  The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells.

Authors:  D C Harnish; M S Scicchitano; S J Adelman; C R Lyttle; S K Karathanasis
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

9.  hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines.

Authors:  D A Thompson; R J Weigel
Journal:  Biochem Biophys Res Commun       Date:  1998-10-09       Impact factor: 3.575

10.  Gene expression profiling of the tumor microenvironment during breast cancer progression.

Authors:  Xiao-Jun Ma; Sonika Dahiya; Elizabeth Richardson; Mark Erlander; Dennis C Sgroi
Journal:  Breast Cancer Res       Date:  2009-02-02       Impact factor: 6.466

View more
  28 in total

1.  Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Authors:  José M A Moreira; Teresa Cabezón; Irina Gromova; Pavel Gromov; Vera Timmermans-Wielenga; Isidro Machado; Antonio Llombart-Bosch; Niels Kroman; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2010-10-08       Impact factor: 6.603

2.  Expression microdissection adapted to commercial laser dissection instruments.

Authors:  Jeffrey C Hanson; Michael A Tangrea; Skye Kim; Michael D Armani; Thomas J Pohida; Robert F Bonner; Jaime Rodriguez-Canales; Michael R Emmert-Buck
Journal:  Nat Protoc       Date:  2011-03-18       Impact factor: 13.491

3.  Immunohistochemical staining, laser capture microdissection, and filter-aided sample preparation-assisted proteomic analysis of target cell populations within tissue samples.

Authors:  Jintang He; Jianhui Zhu; Yashu Liu; Jing Wu; Song Nie; Jason A Heth; Karin M Muraszko; Xing Fan; David M Lubman
Journal:  Electrophoresis       Date:  2013-04-27       Impact factor: 3.535

4.  Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.

Authors:  Lynn M Amon; Sharon J Pitteri; Christopher I Li; Martin McIntosh; Jon J Ladd; Mary Disis; Peggy Porter; Chee Hong Wong; Qing Zhang; Paul Lampe; Ross L Prentice; Samir M Hanash
Journal:  Cancer Res       Date:  2012-02-24       Impact factor: 12.701

5.  Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.

Authors:  Marc Warmoes; Janneke E Jaspers; Thang V Pham; Sander R Piersma; Gideon Oudgenoeg; Maarten P G Massink; Quinten Waisfisz; Sven Rottenberg; Epie Boven; Jos Jonkers; Connie R Jimenez
Journal:  Mol Cell Proteomics       Date:  2012-02-24       Impact factor: 5.911

6.  Protein sets define disease states and predict in vivo effects of drug treatment.

Authors:  David Meierhofer; Christopher Weidner; Ludger Hartmann; Johannes A Mayr; Chung-Ting Han; Frank C Schroeder; Sascha Sauer
Journal:  Mol Cell Proteomics       Date:  2013-04-11       Impact factor: 5.911

7.  Protein expression profile of rat type two alveolar epithelial cells during hyperoxic stress and recovery.

Authors:  Maneesh Bhargava; Sanjoy Dey; Trisha Becker; Michael Steinbach; Baolin Wu; Sang Mee Lee; LeeAnn Higgins; Vipin Kumar; Peter B Bitterman; David H Ingbar; Christine H Wendt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-06       Impact factor: 5.464

Review 8.  Protein biomarkers for subtyping breast cancer and implications for future research.

Authors:  Claudius Mueller; Amanda Haymond; Justin B Davis; Alexa Williams; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2018-01-03       Impact factor: 3.940

9.  Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse.

Authors:  Marcin Imielinski; Sangwon Cha; Tomas Rejtar; Elizabeth A Richardson; Barry L Karger; Dennis C Sgroi
Journal:  Mol Cell Proteomics       Date:  2012-01-12       Impact factor: 5.911

10.  The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.

Authors:  Ling Ma; Xiaodong Tian; Feng Wang; Zhengkui Zhang; Chong Du; Xuehai Xie; Marko Kornmann; Yinmo Yang
Journal:  Cancer Biol Ther       Date:  2016-08-29       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.